Inovio Pharmaceuticals, Inc.
INONASDAQHealthcare● Active
$1.09
+$0.02(+1.87%)
Market Cap$58412952
P/E Ratio—
52W High$2.98
52W Low$1.03
Inovio Pharmaceuticals, Inc.（INO）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · INO · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.07M | $0.22M | $0.83M | $10.26M | $1.77M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.07M | $0.22M | $0.83M | $10.26M | $1.77M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $54.21M | $75.62M | $86.68M | $187.65M | $249.24M |
| G&A Expenses | $32.68M | $37.00M | $47.58M | $90.19M | $53.75M |
| Total Operating Expenses | $86.89M | $112.62M | $144.77M | $277.84M | $302.99M |
| Operating Income | ($86.82M) | ($112.40M) | ($143.94M) | ($267.57M) | ($301.22M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $2.42M | $4.77M | $8.13M | $4.78M | $3.36M |
| Interest Expense | $0.00M | $0.18M | $1.22M | $1.25M | $1.94M |
| Income Before Tax | ($84.95M) | ($107.25M) | ($135.12M) | ($279.82M) | ($303.66M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($84.95M) | ($107.25M) | ($135.12M) | ($279.82M) | ($303.66M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.81 | $-3.95 | $-6.09 | $-14.07 | $-1.42 |
| Wtd Avg Shares | 468.86M | 27.16M | 22.17M | 19.89M | 214.62M |
| EBITDA | ($81.96M) | ($103.95M) | ($130.39M) | ($270.90M) | ($296.56M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Inovio Pharmaceuticals, Inc.
关于Inovio Pharmaceuticals, Inc.（INO）损益表
Inovio Pharmaceuticals, Inc.（INO）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，INO实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.08B)（净利率-130000.00%）。
常见问题
INO · 4 问Inovio Pharmaceuticals, Inc.（INO）2025财年营收为$0.00B，同比down70.0%。
INO revenueINO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09